The Cardiovascular Pathology (CVP) Laboratory at Texas A&M is a trained team of veterinary and comparative pathologists, engineers, postdoctoral fellows, residents, as well as graduate and undergraduate students recruited to improve standard pathology assessment with an integrated methodology to reduce animal numbers, time, and costs, while improving the precision of results in preclinical and clinical studies. The CVP lab provides pathology laboratory support for Texas A&M and its affiliates. This lab also provides pathology and histology services on a fee-for-service basis to outside investigators and medical device companies. Our mission is to provide innovative, objective pathology support of the utmost quality to improve medical device technologies and subsequently, patients’ lives. We aim to bridge translational medical research with clinical applications of treatment strategies in patients with cardiovascular disease. Secondarily, we aim to create learning opportunities and new knowledge for students and the scientific community by engaging in current research in the medical device field. Because of a commitment to high standards of quality and continual investment in the latest technologies and diagnostic techniques, Texas A&M Cardiovascular Pathology has seen consistent growth since it's inception in 2003, expanding from 3 people to currently 24 full and part-time employees. The CVP lab at Texas A&M University focuses on the development and utilization of integrative pathology techniques for the evaluation of implantable devices in humans and animals. The CVP lab specializes in cardiovascular devices such as circulatory assist devices, implantable leads, and intravascular stents.